Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Anti-Cancer Drugs|February 2, 2023
The fibroblast growth factor receptor inhibitor, derazantinib, has strong efficacy in human gastric tumor models and synergizes with paclitaxel in vivoPaul M J McSheehy, Nicole Forster-Gross, Mahmoud El Shemerly, et al.American Journal of Cancer Research|June 9, 2023
The microtubule-targeted agent lisavanbulin (BAL101553) shows anti-tumor activity in lymphoma modelsFilippo Spriano, Luca Aresu, Luciano Cascione, et al.Proceedings of the National Academy of Sciences of the United States of America|June 13, 2002
FLIP switches Fas-mediated glucose signaling in human pancreatic beta cells from apoptosis to cell replicationKathrin Maedler, Adriano Fontana, Frédéric Ris, et al.Cellular Oncology (Dordrecht, Netherlands)|July 30, 2014
eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiationRita Spilka, Christina Ernst, Helmut Bergler, et al.Expert Opinion on Investigational Drugs|October 26, 2021
Derazantinib: an investigational drug for the treatment of cholangiocarcinomaStephan Braun, Paul McSheehy, Karine Litherland, et al.British Journal of Cancer|August 2, 2018
Detection of circulating tumour cell clusters in human glioblastomaIlona Krol, Francesc Castro-Giner, Martina Maurer, et al.Frontiers in Oncology|August 26, 2024
Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combinationElisa Zanini, Nicole Forster-Gross, Felix Bachmann, et al.British Journal of Cancer|August 4, 2020
Phase 1/2a trial of intravenous BAL101553, a novel controller of the spindle assembly checkpoint, in advanced solid tumoursRebecca Kristeleit, Jeffry Evans, L Rhoda Molife, et al.Neuro-Oncology|July 7, 2021
Preclinical modeling in glioblastoma patient-derived xenograft (GBM PDX) xenografts to guide clinical development of lisavanbulin-a novel tumor checkpoint controller targeting microtubulesDanielle M Burgenske, Surabhi Talele, Jenny L Pokorny, et al.Pageof 3